APA (7th ed.) Citation

Zhou, M., Jin, Y., Zhu, S., Xu, C., Li, L., Liu, B., & Shen, J. (2024). A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer. Clinical & Translational Immunology, 13(1), 1. https://doi.org/10.1002/cti2.1483

Chicago Style (17th ed.) Citation

Zhou, Mingzhen, Yuncheng Jin, Sihui Zhu, Chen Xu, Lin Li, Baorui Liu, and Jie Shen. "A Phase II Study to Evaluate the Safety and Efficacy of Anlotinib Combined with Toripalimab for Advanced Biliary Tract Cancer." Clinical & Translational Immunology 13, no. 1 (2024): 1. https://doi.org/10.1002/cti2.1483.

MLA (9th ed.) Citation

Zhou, Mingzhen, et al. "A Phase II Study to Evaluate the Safety and Efficacy of Anlotinib Combined with Toripalimab for Advanced Biliary Tract Cancer." Clinical & Translational Immunology, vol. 13, no. 1, 2024, p. 1, https://doi.org/10.1002/cti2.1483.